SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001520138-24-000263
Filing Date
2024-08-06
Accepted
2024-08-06 06:00:32
Documents
20
Period of Report
2024-08-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT AMENDMENT NO. 1 bivi-20240802_8ka.htm   iXBRL 8-K/A 27852
2 EXHIBIT 3.1 bivi-20240802_8kex3z1.htm EX-3.1 1962
3 EXHIBIT 3.2 bivi-20240802_8kex3z2.htm EX-3.2 2720
7 GRAPHIC image_01.jpg GRAPHIC 621087
8 GRAPHIC image_02.jpg GRAPHIC 481150
9 GRAPHIC image_03.jpg GRAPHIC 394780
10 GRAPHIC image_04.jpg GRAPHIC 427472
11 GRAPHIC image_05.jpg GRAPHIC 267616
  Complete submission text file 0001520138-24-000263.txt   3217832

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bivi-20240802.xsd EX-101.SCH 3027
5 XBRL LABEL FILE bivi-20240802_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bivi-20240802_pre.xml EX-101.PRE 22367
22 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20240802_8ka_htm.xml XML 4718
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-39015 | Film No.: 241176882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)